The invention discloses a pharmaceutical hemostatic liquid foam base preparation comprising albumin as foaming agent and a fibrinogen precipitating substance and optionally a coagulation inducing agent wherein albumin as foaming agent is present in native form a method for the production of a transient hemostatic liquid foam the transient hemostatic liquid foam and a kit for making the foam.